期刊文献+

压力反射刺激疗法治疗顽固性高血压 被引量:4

Baroreflex Stimulation Therapy in Treatment of Refractory Hypertension
下载PDF
导出
摘要 顽固性高血压患者往往有血压高、病程长、与心血管及肾脏事件高危相关等特点,因此简单、安全、有效地控制血压刻不容缓。非药物治疗可弥补当前药物疗法的不足,现就压力反射刺激疗法治疗顽固性高血压的机制及安全有效性进展进行综述。 Patients with resistant hypertension always have high blood pressure,long duration and associated with cardiovascular and kidney events. To find simple,safe and effective antihypertensive treatment is an urgent task. Non-drug therapies may remedy the deficiency of current drug therapies. The paper summarizes the machanism of baroreflex activation treatment for resistant hypertension and security effectiveness.
出处 《心血管病学进展》 CAS 2015年第1期48-51,共4页 Advances in Cardiovascular Diseases
关键词 顽固性高血压 压力感受器 机制 评价 resistant hypertension baroreceptors machanism assessment
  • 相关文献

参考文献3

二级参考文献120

  • 1Calhoun DA,Jones D, Textor S, et al. Resistant hypertension:diagnosis, evaluation, and treatment. A scientific statement fromthe American Heart Association Professional Education Committeeof the Council for High Blood Pressure Research. Hypertension,2008, 51:1403-1419.
  • 2Chobanian AV, Bakris GL, Black HR, et al. Joint NationalCommittee on Prevention,Detection,Evaluation, and Treatmentof High Blood Pressure. National Heart, Lung, and BloodInstitute; National Heart, Lung, and Blood Institute; NationalHigh Blood Pressure Education Program Coordinating Committee.Seventh report of the Joint National Committee on prevention,detection, evaluation, and treatment of high blood pressure.Hypertension, 2003,42 : 1206-1252.
  • 3Dahlof B,Sever PS, Poulter NR, et al. ASCOT Investigators.Prevention of cardiovascular events with an antihypertensiveregimen of amlodipine adding perindopril as required versusatenolol adding bendroflumethiazide as required, in the AngloScandinavian Cardiac Outcomes Trial-Blood Pressure LoweringArm ( ASCOT-BPLA) : a multicentre randomised controlled trial.Lancet,2005,366 : 895 -906.
  • 4Jamerson K,Weber MA, Bakris GL, et al. ACCOMPLISH TrialInvestigators. Benazepril plus amlodipine or hydrochlorothiazidefor hypertension in high-risk patients. N Engl J Med,2008,359:2417-2428.
  • 5Schmieder RE,Redon J, Grassi G,et al. ESH position paper:renal denervation - an interventional therapy of resistanthypertension. J Hypertens, 2012, 30:837-841.
  • 6Tsioufis C, Kordalis A, Flessas D, et al. Pathophysiology ofresistant hypertension : the role of sympathetic nervous system.Int J Hypertens, 2011,ID :642416.
  • 7Barajas L,Liu L, Powers K. Anatomy of the renal innervation:intrarenal aspects and ganglia of origin. Can J PhysiolPharmacol, 1992, 70:735-749.
  • 8Hering D,Mahfoud F, Walton AS, et al. Renal denervation inmoderate to severe CKD. J Am Soc Nephrol, 2012, 23 : 1250-1257.
  • 9Laurent S, Schlaich M, Esler M. New drugs, procedures, anddevices for hypertension. Lancet, 2012,380:591-600.
  • 10Aucott L,Poobalan A,Smith WC,et al. Effects of weight loss inoverweight/obese individuals and long-term hyper-tensionoutcomes: a systematic review. Hypertension, 2005,45 : 1035-1041.

共引文献65

同被引文献29

引证文献4

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部